Micro Spirometer From the World Leader in Spirometry
At only $ 895 it is the least expensive full spirometer available in the USA !
• Simple , accurate , rugged and proven Fleisch Pneumotachometer technology
• Fully Reimbursable in as few as 15 patients *
• 8 ½ ” x 11 ” Flow Volume Loop Reports with Interpretation
• Optional Accessory Flow Head Extender allows the patient to hold only the flow sensor and the tech securely holds the device , giving a better view of the screen .
# 3416
Special Bundle Promotional Price until June 30 , 2017 : Only $ 1,199 !
# 3415
Includes Micro Spirometer , Flow Head Extender , 3L Cal Syringe , and 150 Disposable
Filters ( that ’ s over a $ 1,500.00 value !)
* National Average $ 37 Screening ; $ 62 Pre-Post BD www . vitalograph . com ( 800 ) 255-6626
disease interventions ;
• Customize disease-prevention
strategies ;
• Prescribe more effective drugs and
avoid prescribing drugs with predictable side effects ;
• Have a higher probability of desired
outcomes thanks to better targeted therapies ;
• Reduce the time , cost , and failure rate
of pharmaceutical clinical trials , and
• Eliminate trial-and-error inefficiencies
that inflate health care costs and undermine care Similarly , genomic medicine is also changing laboratory testing protocols to match specific patient needs . An example is genetic testing for BRCA1 and BRCA2 mutations that can indicate an individual ’ s risk for developing breast or ovarian cancer .
The results of gene-based molecular diagnostic laboratory tests can then be used to determine the benefits and harms for an individual taking prescribed medications ( known as companion diagnostics tests ). Information on an individual ’ s drug metabolism , for example , can yield information on who might benefit most from a drug and those at risk for atypical adverse reactions . Tests can also inform the optimal dose or treatment frequency
needed to achieve a desired therapeutic effect in an individual patient . Examples are :
• HER2 / neu testing to guide the
prescription of the cancer drug Herceptin for breast cancer .
• UGT1A1 testing to guide the dosage
of the chemotherapy drug Irinotecan for metastatic colectoral cancer .
Patient – centered healthcare requires patient engagement through patient empowerment
As the healthcare industry starts to reengineer care delivery to accommodate these new advances and demands , providers on the front lines of change are recognizing the need for increasing patients ’ engagement in their own health care . This is based on the knowledge that it is impossible to manage the health of a population without getting patients more involved in self-management and the modification of their own risk factors . An empowered , activated patient :
■ understands their health condition and its effect on their body
■ feels able to participate in decisionmaking with their health care professionals
■ feels able to make informed choices
LabOratory :
Educating Patients About Their Lab Tests continued on page 13
11